BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30304573)

  • 1. Physicians' views on patient participation in choice of oral anticoagulants in atrial fibrillation-a qualitative study.
    Aarnio E; Huupponen R; Hämeen-Anttila K; Merikoski M; Puhakka J; Korhonen MJ
    Basic Clin Pharmacol Toxicol; 2019 Apr; 124(4):416-422. PubMed ID: 30304573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients' and physicians' experiences of atrial fibrillation consultations and anticoagulation decision-making: A multi-perspective IPA design.
    Borg Xuereb C; Shaw RL; Lane DA
    Psychol Health; 2016; 31(4):436-55. PubMed ID: 26540308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a shared decision-making tool to assist patients and clinicians with decisions on oral anticoagulant treatment for atrial fibrillation.
    Kaiser K; Cheng WY; Jensen S; Clayman ML; Thappa A; Schwiep F; Chawla A; Goldberger JJ; Col N; Schein J
    Curr Med Res Opin; 2015 Dec; 31(12):2261-72. PubMed ID: 26390360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients' and physicians' perceptions and attitudes about oral anticoagulation and atrial fibrillation: a qualitative systematic review.
    Mas Dalmau G; Sant Arderiu E; Enfedaque Montes MB; Solà I; Pequeño Saco S; Alonso Coello P
    BMC Fam Pract; 2017 Jan; 18(1):3. PubMed ID: 28086887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicians' views and experiences of prescribing oral anticoagulants for stroke prevention in atrial fibrillation: A qualitative meta-synthesis.
    Pritchett RV; Clarke JL; Jolly K; Clarkesmith D; Bem D; Turner GM; Thomas GN; Lane DA
    PLoS One; 2020; 15(5):e0232484. PubMed ID: 32379847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicians' Perceptions of Their Patients' Attitude and Knowledge of Long-Term Oral Anticoagulant Therapy in Bulgaria.
    Runev N; Potpara T; Naydenov S; Vladimirova A; Georgieva G; Manov E
    Medicina (Kaunas); 2019 Jun; 55(7):. PubMed ID: 31248007
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of decision aids on oral anticoagulant prescribing among physicians: a randomised trial.
    Baicus C; Delcea C; Dima A; Oprisan E; Jurcut C; Dan GA
    Eur J Clin Invest; 2017 Sep; 47(9):649-658. PubMed ID: 28682461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription Patterns of Non-Vitamin K Oral Anticoagulants Across Indications and Factors Associated with Their Increased Prescribing in Atrial Fibrillation Between 2012-2015: A Study from the Norwegian Prescription Database.
    Urbaniak AM; Strøm BO; Krontveit R; Svanqvist KH
    Drugs Aging; 2017 Aug; 34(8):635-645. PubMed ID: 28710707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring patient-provider decision-making for use of anticoagulation for stroke prevention in atrial fibrillation: Results of the INFORM-AF study.
    Pokorney SD; Bloom D; Granger CB; Thomas KL; Al-Khatib SM; Roettig ML; Anderson J; Heflin MT; Granger BB
    Eur J Cardiovasc Nurs; 2019 Apr; 18(4):280-288. PubMed ID: 30418049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing primary care physicians' prescribing behavior of anticoagulant therapy for the management of patients with non-valvular atrial fibrillation in Singapore: a qualitative research study.
    Chaterji S; Lian LG; Lee TY; Chua L; Wee SY; Yap SL; K DL; Tan NC
    BMC Fam Pract; 2021 May; 22(1):101. PubMed ID: 34034648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Values and Preferences of Physicians and Patients With Nonvalvular Atrial Fibrillation Who Receive Oral Anticoagulation Therapy for Stroke Prevention.
    Andrade JG; Krahn AD; Skanes AC; Purdham D; Ciaccia A; Connors S
    Can J Cardiol; 2016 Jun; 32(6):747-53. PubMed ID: 26774235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation.
    Marzec LN; Wang J; Shah ND; Chan PS; Ting HH; Gosch KL; Hsu JC; Maddox TM
    J Am Coll Cardiol; 2017 May; 69(20):2475-2484. PubMed ID: 28521884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients' experiences of atrial fibrillation and non-vitamin K antagonist oral anticoagulants (NOACs), and their educational needs: A qualitative study.
    Clarkesmith DE; Lip GYH; Lane DA
    Thromb Res; 2017 May; 153():19-27. PubMed ID: 28314139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the barriers to using oral anticoagulants among long-term aspirin users with atrial fibrillation - a qualitative study.
    Ng VWS; Siu CW; Chiu PKC; Kng CPL; Jamieson E; Wong ICK; Lam MPS
    BMC Health Serv Res; 2020 Nov; 20(1):1084. PubMed ID: 33238989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients' and health professionals' views and experiences of atrial fibrillation and oral-anticoagulant therapy: a qualitative meta-synthesis.
    Borg Xuereb C; Shaw RL; Lane DA
    Patient Educ Couns; 2012 Aug; 88(2):330-7. PubMed ID: 22738822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to oral anticoagulant therapy in patients with atrial fibrillation. Focus on non-vitamin K antagonist oral anticoagulants.
    Raparelli V; Proietti M; Cangemi R; Lip GY; Lane DA; Basili S
    Thromb Haemost; 2017 Jan; 117(2):209-218. PubMed ID: 27831592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Web-based education resources informing patients about stroke prevention in atrial fibrillation.
    Pandya E; Bajorek BV
    J Clin Pharm Ther; 2016 Dec; 41(6):667-676. PubMed ID: 27704588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study.
    Toyoda K; Arihiro S; Todo K; Yamagami H; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Mochizuki H; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Kario K; Sato S; Koga M;
    Int J Stroke; 2015 Aug; 10(6):836-42. PubMed ID: 25581108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why isn't warfarin prescribed to patients with nonrheumatic atrial fibrillation?
    Beyth RJ; Antani MR; Covinsky KE; Miller DG; Chren MM; Quinn LM; Landefeld CS
    J Gen Intern Med; 1996 Dec; 11(12):721-8. PubMed ID: 9016418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk Factor.
    Potpara TS; Dagres N; Mujović N; Vasić D; Ašanin M; Nedeljkovic M; Marin F; Fauchier L; Blomstrom-Lundqvist C; Lip GY
    Adv Ther; 2017 Feb; 34(2):357-377. PubMed ID: 27933569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.